Spectral Molecular Imaging Readies IDE For Melanoma Detection Trial
This article was originally published in The Gray Sheet
Executive Summary
Spectral Molecular Imaging will submit an investigational device exemption application to FDA within three months for its SkinSpect system to aid early melanoma detection.